UNSPSC 51263130: Pacrinolol

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51263130

Definition

This classification denotes a beta-adrenergic blocking agent with the molecular formula C23H28N2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CHE211JZXQ, chemically known as (-)-p-(3-((3,4-dimethoxyphenetyl)amino)-2-hydroxypropoxy)-beta-methylcinnamonitrile but generally known as pacrinolol, which bears US NIH Compound Identifier 6436098. European Medicines Agency schedules Pacrinolol in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09584MIG.

Read the full definition

The term PACRINOLOL is an International Non-Proprietary Name. PACRINOLOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pacrinolol under HS 29269095 and SITC 51484. As of Q4 2014, PACRINOLOL remains the US FDA Preferred Term for this commodity. Pacrinolol bears US NLM identifiers UMLS ID C0135043 and NCI Concept Code C90800. SMILES: O(CC(O)CNCCC1CC(OC)C(OC)CC1)C1CCC(CC1)/C(=C/C#N)C.

About UNSPSC 51263130

UNSPSC 51263130 Pacrinolol is a Commodity code that appears in state and local procurement records with limited recent activity aligned to its nominal pharmaceutical scope. The single recent opportunity on record—Seminole County, Florida's IFB 60459723LAS—involves procurement of naloxone and safe drug deactivation systems rather than pacrinolol specifically, suggesting either a cataloging mismatch or that this code is being used as a catch-all for emergency-response pharmaceuticals and related equipment. The work solicited under this code involves competitive acquisition of pharmaceutical supplies and harm-reduction equipment for public health agencies, with vendors required to meet standard compliance requirements including drug-free workplace certification, E-Verify employment authorization, and federal environmental and contracting standards.

Seminole County, Florida represents the primary recent issuing body. The naloxone and drug deactivation systems procurement, posted June 30, 2026, with a response deadline of July 26, 2023, called for 1,900 units of naloxone and 800 safe drug deactivation systems on an annual basis with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract structure includes an initial two-year term with an option for one-year renewal, fixed-fee pricing, and a three-month probationary termination clause. Vendors must provide unit costs for each line item, include all shipping and delivery costs in their proposals, and carry workers' compensation, commercial general liability, and professional liability insurance. The procurement indicates potential FEMA funding with attendant federal compliance obligations under the Clean Air Act and Federal Water Pollution Control Act.

Quick answers

What is UNSPSC 51263130?

UNSPSC 51263130 is Pacrinolol, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51263130?

UNSPSC 51263130 maps to 1 NIGP code, 26912 Autonomic Drugs.

On GovTribe

See everything under UNSPSC 51263130

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code